BRD4 is significantly upregulated in HCC patients and in liver cancer cell lines, and the overexpression of BRD4 in cancer tissues is correlated with poor prognosis in HCC patients (Tsang et al., 2019; Zhang et al., 2015). The gene discussed is BRD4; the disease is hepatocellular carcinoma.